Myomo (MYO) Cash & Equivalents Growth (3y) (2019 - 2025)
Myomo (MYO) Cash & Equivalents Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 32.23% |
| 10 | Myomo | 73.79 Mn | 54.83 Mn | - | 40.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.12% |
| Sep 30, 2025 | 20.33% |
| Jun 30, 2025 | 14.79% |
| Mar 31, 2025 | 15.94% |
| Dec 31, 2024 | 16.82% |
| Sep 30, 2024 | -17.82% |
| Jun 30, 2024 | -24.85% |
| Mar 31, 2024 | -32.11% |
| Dec 31, 2023 | -17.51% |
| Sep 30, 2023 | -19.64% |
| Jun 30, 2023 | -5.85% |
| Mar 31, 2023 | -12.29% |
| Dec 31, 2022 | 6.18% |
| Sep 30, 2022 | 19.68% |
| Jun 30, 2022 | 15.35% |
| Mar 31, 2022 | 11.91% |
| Dec 31, 2021 | 33.39% |
| Sep 30, 2021 | 11.50% |
| Jun 30, 2021 | 5.64% |
| Mar 31, 2021 | 7.16% |